Investors / Malta / Presight Capital
Presight Capital
Venture capital · Sliema, Malta · Europe
Presight Capital is an investment firm that backs founders globally from Seed to IPO. Its portfolio spans deep tech and life sciences companies, including biotech, neurotech, fusion energy, robotics and consumer beverages.
Invests inHealthcare & BiotechSpace & Defense
In its own wordsdeep techlife sciencesbiotechhealthcarefusion energyrobotics
Your fit with Presight Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPresight Capital lists 11 checked portfolio companies on its own site and is named in 4 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 25% of the companies with a known first round. Its largest themes are Healthcare & Biotech (67%), Space & Defense (17%) and Education (8%). 67% of its companies are based in United States. It invests most often alongside Founders Fund, Gaingels and 2050 Capital.
Counts come from funding rounds that name Presight Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Presight Capital's whole history. Rounds on record name 4 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 25% |
| Series A | 25% |
| Series B | 25% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 1 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 60th | 25% of entries at pre-seed or seed |
| Evidence | 96th | 27% of companies confirmed by a round |
| Sector focus | 91th | 67% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Founders Fund | 2 |
| Gaingels | 2 |
| 2050 Capital | 1 |
| 8VC | 1 |
| AAF Management | 1 |
| AMR Action Fund | 1 |
| ARK Venture Fund | 1 |
| Alumni Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 67% | 15% |
| Space & Defense | 17% | 3% |
| Education | 8% | 7% |
| Industrial & Manufacturing | 8% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Presight Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Presight Capital| Date | Company | Stage |
|---|---|---|
| 15 Apr 2026 | Series C+ | |
| 16 Oct 2025 | Series B Led | |
| 21 Aug 2025 | Series A | |
| 1 Mar 2025 | Seed |
Round details for Presight Capital
Amounts, full round histories and every co-investor in Presight Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AbCellera develops and studies antibody medicines for various therapeutic areas, including endocrinology, immunology, and autoimmunity. | Healthcare & Biotech | Portfolio page | ||
| Alloy Therapeutics provides antibody discovery services and technology to help bring medicines to patients faster. | Healthcare & Biotech | Apr 2026Series C+ | Page + round | |
| AtaiBeckley develops mental health treatments. | Healthcare & Biotech | Portfolio page | ||
| Blackrock Neurotech develops neurotechnology that improves patients' lives, particularly those with paralysis and other neurological disorders. | Healthcare & Biotech | Portfolio page | ||
| Cleerly analyzes and treats heart disease using personalized analysis and treatment methods. | Healthcare & Biotech | Portfolio page | ||
| TRIP sells various products such as magnesium drinks, gummies, and powders to help people relax and calm down. | Healthcare & Biotech | Portfolio page | ||
| General Fusion develops fusion energy technology to produce usable energy | EducationIndustrial & Manufacturing | Aug 2025Series A | Page + round | |
| The company provides an agent-native outbound engine for finding leads and running outreach campaigns | Space & DefenseSpace & Defense | Mar 2025Seed | Funding round | |
| Peptilogics is a surgical therapeutics company that develops a novel anti-biofilm drug to cure and prevent medical device-related infections. | Healthcare & Biotech | Oct 2025Series B | Page + round | |
| Portfolio page | ||||
| Umoja Biopharma develops in vivo CAR T cell therapies for the treatment of cancers and other conditions. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- presight.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 1 Mar 2025
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Presight Capital's profile as data
Pull Presight Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/presight.vc
# also
GET /v1/firms/presight.vc/portfolio
GET /v1/firms/presight.vc/coinvestors
GET /v1/firms/presight.vc/news